Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus

被引:2
作者
Jiang, Lijun [1 ]
Zhi, Shufeng [1 ]
Wei, Chenxi [1 ]
Rong, Zanhua [1 ]
Zhang, Huifeng [1 ]
机构
[1] Hebei Med Univ, Hosp 2, Dept Pediat, Shijiazhuang, Peoples R China
来源
FRONTIERS IN PEDIATRICS | 2023年 / 11卷
关键词
25(OH)D; initial-onset childhood SLE; SLEDAI-2K; lupus nephritis; renal pathology; VITAMIN-D DEFICIENCY; HEALTHY-INDIVIDUALS; CLASSIFICATION; VALIDATION; MANAGEMENT; CRITERIA; UPDATE; DAMAGE; INDEX;
D O I
10.3389/fped.2023.1252594
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Vitamin D deficiency is common in patients with systemic lupus erythematosus (SLE) and may affect their disease activity and severity.Objective: This study aims to assess the vitamin D status in patients with initial-onset SLE during childhood and its association with the clinical and laboratory markers of disease activity.Method: This is a retrospective study that includes 168 patients with initial-onset SLE during childhood and 109 healthy children as controls. Clinical and laboratory data were recorded. The area under the curve (AUC) method was used to evaluate the efficacy of double-stranded deoxyribonucleic acid (dsDNA), lower 25(OH)D and complement 3 (C3) alone and in combination to diagnose the presence of renal damage in children with SLE.Result: Compared with the controls (25.53 +/- 7.02 ng/ml), patients with initial-onset SLE during childhood have lower serum 25(OH)D levels (18.63 +/- 5.32 ng/ml) (P < 0.05). Among patients with initial-onset SLE during childhood, SLEDAI-2K scores are significantly higher in the vitamin D insufficiency (median = 14.5) and vitamin D deficiency (median = 14.0) groups than in the vitamin D sufficiency group (median = 9.0) (P < 0.05). Patients with initial-onset SLE during childhood with lower 25(OH)D levels are more likely to have lupus nephritis (LN) and a higher SDI score (P < 0.05). Compared with patients with other types of LN (16.69 +/- 3.90 ng/ml), patients with type V LN have lower levels of 25(OH)D (12.27 +/- 3.53 ng/ml) (P < 0.05). The AUC was 0.803 when dsDNA antibody, 25(OH)D level and C3 were used in combination to diagnose LN in patients with SLE.Conclusion: Vitamin D deficiency and insufficiency are closely related to an increase in SLEDAI and SDI scores. Significant decrease in vitamin D level is a risk factor for LN.
引用
收藏
页数:9
相关论文
共 41 条
  • [1] Vitamin D Deficiency in Egyptian Systemic Lupus Erythematosus Patients: How Prevalent and Does It Impact Disease Activity?
    Abaza, Nouran M.
    El-Mallah, Reem M.
    Shaaban, Asmaa
    Mobasher, Sameh A.
    Al-Hassanein, Khaled F.
    Zaher, Amr A. Abdel
    El-Kabarity, Rania H.
    [J]. INTEGRATIVE MEDICINE INSIGHTS, 2016, 11 : 27 - 33
  • [2] RETRACTED: The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial (Retracted Article)
    Abou-Raya, Anna
    Abou-Raya, Suzan
    Helmii, Madihah
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (03) : 265 - 272
  • [3] Update on Lupus Nephritis
    Almaani, Salem
    Meara, Alexa
    Rovin, Brad H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (05): : 825 - 835
  • [4] Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters
    Bogaczewicz, J.
    Sysa-Jedrzejowska, A.
    Arkuszewska, C.
    Zabek, J.
    Kontny, E.
    McCauliffe, D. P.
    Wozniacka, A.
    [J]. LUPUS, 2012, 21 (05) : 477 - 484
  • [5] Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
    Bouillon, Roger
    Marcocci, Claudio
    Carmeliet, Geert
    Bikle, Daniel
    White, John H.
    Dawson-Hughes, Bess
    Lips, Paul
    Munns, Craig F.
    Lazaretti-Castro, Marise
    Giustina, Andrea
    Bilezikian, John
    [J]. ENDOCRINE REVIEWS, 2019, 40 (04) : 1109 - 1151
  • [6] Vitamin D Levels are Associated with Disease Activity and Damage Accrual in Systemic Lupus Erythematosus Patients
    Correa-Rodriguez, Maria
    Pocovi-Gerardino, Gabriela
    Callejas-Rubio, Jose-Luis
    Rios-Fernandez, Raquel
    Martin-Amada, Maria
    Cruz-Caparros, Maria-Gracia
    DelOlmo-Romero, Sara
    Ortego-Centeno, Norberto
    Rueda-Medina, Blanca
    [J]. BIOLOGICAL RESEARCH FOR NURSING, 2021, 23 (03) : 455 - 463
  • [7] Dang XQ., 2018, Chinese Journal of Pediatrics, V56, P95, DOI [10.3760/cma.j.issn.0578-1310.2018.02.004, DOI 10.3760/CMA.J.ISSN.0578-1310.2018.02.004]
  • [8] Dickerson Roland N, 2004, JPEN J Parenter Enteral Nutr, V28, P133, DOI 10.1177/0148607104028003133
  • [9] Update on the diagnosis and management of systemic lupus erythematosus
    Fanouriakis, Antonis
    Tziolos, Nikolaos
    Bertsias, George
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01) : 14 - 25
  • [10] 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
    Fanouriakis, Antonis
    Kostopoulou, Myrto
    Alunno, Alessia
    Aringer, Martin
    Bajema, Ingeborg
    Boletis, John N.
    Cervera, Ricard
    Doria, Andrea
    Gordon, Caroline
    Govoni, Marcello
    Houssiau, Frederic
    Jayne, David
    Kouloumas, Marios
    Kuhn, Annegret
    Larsen, Janni L.
    Lerstrom, Kirsten
    Moroni, Gabriella
    Mosca, Marta
    Schneider, Matthias
    Smolen, Josef S.
    Svenungsson, Elisabet
    Tesar, Vladimir
    Tincani, Angela
    Troldborg, Anne
    van Vollenhoven, Ronald
    Wenzel, Joerg
    Bertsias, George
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (06) : 736 - 745